Inmune Bio, Inc. — Institutional Ownership

Which tracked institutions hold INMB, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.

16
Funds holding
$1773699
Total value held
Selling
6 added/new · 10 reduced
# Institution Value Shares Δ Shares Change (QoQ)
1 Blackrock, Inc. $507930 311613 -882499 -73.90%
2 Raymond James Financial Inc $347182 212995 +9750 +4.80%
3 Goldman Sachs Group Inc $301949 185245 -46341 -20.01%
4 Ubs Group Ag $179973 110413 +110413 NEW BUY
5 State Street Corp $152182 93363 -197516 -67.90%
6 Pnc Financial Services Group, Inc. $69501 42638 +2518 +6.28%
7 Northern Trust Corp $61402 37670 -146555 -79.55%
8 Jpmorgan Chase & Co $39162 24174 -9071 -27.29%
9 Bank Of New York Mellon Corp $34603 21229 -32399 -60.41%
10 Stonex Group Inc. $30614 21513 +21513 NEW BUY
11 Barclays Plc $23404 14358 -4288 -23.00%
12 Morgan Stanley $14431 8853 -35758 -80.16%
13 Royal Bank Of Canada $7000 4279 +1595 +59.43%
14 Wells Fargo & Company/Mn $4165 2555 -8087 -75.99%
15 Citigroup Inc $160 98 -1705 -94.56%
16 Us Bancorp \De\ $41 25 +25 NEW BUY

Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.